Mars Finance news, on August 27, according to GMGN data, Bio Protocol's first BioAgent Launch project Aubrai briefly surpassed a market value of 20 million dollars after going live on the Base network, but has since fallen back to 9 million dollars, with a trading volume of 6.4 million dollars in 3 hours.